| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/2011 | CN101203496B Process for preparing pure amorphous rosuvastatin calcium |
| 04/20/2011 | CN101200466B Heterocyclic compounds having antithrombotic activity, preparation method and uses thereof |
| 04/20/2011 | CN101199856B Oxygen-carrying anti-shock medicament |
| 04/20/2011 | CN101199534B Anti-tumor function of raw panoxadiol derivative |
| 04/20/2011 | CN101195609B Method for producing 5,6-dimethyl xanthenone-4-acetic acid, derivant and pharmaceutical formulation produced with the method |
| 04/20/2011 | CN101185627B Nilotinib sustained-release implant for treating solid tumor |
| 04/20/2011 | CN101176713B Carmustine sustained-release implantation agent for curing entity tumour |
| 04/20/2011 | CN101171237B Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 04/20/2011 | CN101167728B Doxazosin-mesylate controlled-releasing tablet and preparation method thereof |
| 04/20/2011 | CN101164557B Medical composition for preventing and/or treating bone matrix's loss |
| 04/20/2011 | CN101164535B Anti-heatstroke use of teprenone |
| 04/20/2011 | CN101161646B Ketones compound preventing cells from oxidation damage, preparation method and uses thereof |
| 04/20/2011 | CN101152308B Traditional Chinese medicine composition for treating abdominal pain and lax, and method for preparing the same |
| 04/20/2011 | CN101152188B Vitamin D* solid dispersion peridium patch and method for preparing the same |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/20/2011 | CN101139292B 4'-oxo carboxyl acid diphenyl ethylene alkyl derivative |
| 04/20/2011 | CN101129367B S-omeprazole solid dispersion and composition containing the dispersion |
| 04/20/2011 | CN101120913B Ftibamzone chrisma with PEG-200 as co-solvent |
| 04/20/2011 | CN101113144B New compound and method for preparing same |
| 04/20/2011 | CN101107246B Anti-trypanosomiasis agent |
| 04/20/2011 | CN101095681B Alfuzosin Hydrochloride permeating pump type controlled-release preparation and method for preparing the same |
| 04/20/2011 | CN101077862B D-glucose-L-amino acid, preparation method and application thereof |
| 04/20/2011 | CN101077353B Cardiac and cerebral vascular disease treating medicine |
| 04/20/2011 | CN101069692B Medicine preparation containing centella triterpenic genine and preparing method thereof |
| 04/20/2011 | CN101066290B Hongyao ointment and its preparation |
| 04/20/2011 | CN101062937B 18alpha- liquorice acid derivatives and preparation thereof |
| 04/20/2011 | CN101053553B Biodegradable fluorourcacil polyester medicine-carried nanospheres and its preparation method |
| 04/20/2011 | CN101049362B External remedy for treating onychomycosis |
| 04/20/2011 | CN101039935B New piperidine antibiotics |
| 04/20/2011 | CN101028510B Snake gallbladder for artificial medicine and its production |
| 04/20/2011 | CN101028385B Medicine for treating alvelysis |
| 04/20/2011 | CN101015567B Medicine composition for treating ophthalmological diseases and preparing process thereof and quality control method |
| 04/20/2011 | CN101010312B Quaternary salt CCR2 antagonists |
| 04/20/2011 | CN101010299B Six-membered heterocycles useful as serine protease inhibitors |
| 04/20/2011 | CN101001851B Hydroxyamide compounds having activity as inhibitors of histone deacetylase (HDAC) |
| 04/20/2011 | CN100998637B Traditional Chinese medicine for treating bone tuberculosis and arthritis |
| 04/20/2011 | CA2683248A1 Solubilized formulation of docetaxel |
| 04/20/2011 | CA2683032A1 Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928244 Isoxazolidine small molecules; cancer, hyperproliferation disorders; blocking antiapoptotic function |
| 04/19/2011 | US7928243 e.g. N-{(2Z)-3-[4-(4-isopropoxyphenoxy)phenyl]-1-methylprop-2-enyl}acetamide; antidiabetic agent; type II diabetes, atherosclerosis and cardiovascular diseases |
| 04/19/2011 | US7928239 Anticarcinogenic agents |
| 04/19/2011 | US7928237 Fused ring azadecalin glucocorticoid receptor modulators |
| 04/19/2011 | US7928233 Spiroindolinone pyridine derivatives |
| 04/19/2011 | US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 04/19/2011 | US7928225 Oxabispidine compounds for the treatment of cardiac arrhythmias |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928216 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 04/19/2011 | US7928209 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 04/19/2011 | US7928147 Buffer, surfactant, chelate compound, nonionic preservative microbiocide; sensitivity; wound healing agents; topical, drug delivery |
| 04/19/2011 | US7928146 Topical applying adrenergic blocking agent, nitric oxide synthase inhibitor, prostaglandin, dopamine, morphine and 5-hydroxytryptamine; topical applying |
| 04/19/2011 | US7928144 Antiinflammatory and analgesic preparation for external use |
| 04/19/2011 | US7928143 Method for preventing and/or treating neurodegenerative diseases |
| 04/19/2011 | US7928142 Compositions containing retinoid and beta-aminoisobutyic acid derivatives |
| 04/19/2011 | US7928141 Mixture comprising dexamethasone, vitamin B, metronidazole, berberine, etamsylate, gentamicin, chymotrypsin, methylene blue trihydrate and sodium bicarbonate for improving effectiveness of local anesthetics |
| 04/19/2011 | US7928140 Benzothiazole PI3 kinase modulators for cancer treatment |
| 04/19/2011 | US7928139 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 04/19/2011 | US7928138 Marine actinomycete taxon for drug and fermentation product discovery |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928136 Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety |
| 04/19/2011 | US7928134 5-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonists |
| 04/19/2011 | US7928133 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/19/2011 | US7928132 Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
| 04/19/2011 | US7928131 Imidazole compounds |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928128 Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 04/19/2011 | US7928127 Inhibitors of matrix metallaproteinases |
| 04/19/2011 | US7928126 Cyanopyridine derivative and use thereof as medicine |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928123 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/19/2011 | US7928122 Modulators of cellular adhesion |
| 04/19/2011 | US7928121 2-[1-(5-Chloro-2,4-difluoro-benzenesulfonyl)-piperidin-4-ylmethyl]-1,2,3,4-tetrahydroisoquinolinehydrochloride; antidepressant, anxiolytic, hypotensive agent; psychosis, schizophrenia, migraine, cognition activity; pharmacokinetics |
| 04/19/2011 | US7928120 Cyanoisoquinoline compounds and methods of use thereof |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928115 Methods of treating travelers diarrhea and hepatic encephalopathy |
| 04/19/2011 | US7928114 Anticancer agents |
| 04/19/2011 | US7928113 Integrin-binding small molecules |
| 04/19/2011 | US7928112 Substituted 5,6,7,8-tetrahydropyrido[4,3-D]pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/19/2011 | US7928111 Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
| 04/19/2011 | US7928109 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 04/19/2011 | US7928108 Pyridinone derivative for the treatment of premature ejaculation |
| 04/19/2011 | US7928107 Quinazolines useful as modulators of ion channels |
| 04/19/2011 | US7928106 Aza-pyridopyrimidinone derivatives |
| 04/19/2011 | US7928105 Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones |
| 04/19/2011 | US7928104 Enhances sensitivity to radiotherapy and chemotherapy; synergistic; hydrolysis of a 2-methoxyquinoline or 2-methoxyquinoxaline; cyclization of a N-phenyl phenylacrylamide; or condensation of an o-benzenediamine with a keto-ester; preferred oxalate salt; side effect reduction |
| 04/19/2011 | US7928103 Compounds which modulate the CB2 receptor |
| 04/19/2011 | US7928102 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam |
| 04/19/2011 | US7928101 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 04/19/2011 | US7928100 Quinolone analogs and methods related thereto |
| 04/19/2011 | US7928099 Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists |
| 04/19/2011 | US7928098 Therapeutic and/or preventive agents for a sleep disorder |
| 04/19/2011 | US7928097 Photoreactive compounds and compositions |
| 04/19/2011 | US7928096 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 04/19/2011 | US7928095 DNA topoisomerase I inhibitors; anticancer agents |
| 04/19/2011 | US7928094 Treatment of diabetes with copper binding compounds |
| 04/19/2011 | US7928092 Formulations and methods of treating inflammatory bowel disease |
| 04/19/2011 | US7928091 Cathepsin cysteine protease inhibitors |
| 04/19/2011 | US7928090 topically applying to the skin of a subject a composition comprising at least one acyl glucosamine derivative such as N-retinoyl-D-glucosamine; preventing or treating symptoms or diseases related to dermatopathy caused by dryness, UV rays and aging such as wrinkles and sags of the skin, skin diseases |